文献速递胃肠动力与功能性疾病

随机对照试验:无麸质饮食对肠易激综合征症状及肠道微环境的影响

Randomised controlled trial: effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome.
PubMed 文献 · Aliment Pharmacol Ther · 2022-09-29

该随机对照试验纳入20例肠易激综合征(IBS)患者和18名健康对照,在兩個14天干预期内分别添加麸质(14克/天)或米粉。无麸质期IBS症状改善(p=0.02),麸质期未改善,两种干预间无差异;无麸质期稀便减少(p=0.01);代谢物谱可预测无麸质饮食应答。

要点

  • 无麸质饮食期IBS症状改善(p=0.02),含麸质期未改善,两干预间无差异。
  • 无麸质干预期IBS患者稀便报告减少(p=0.01)。
  • 干预前代谢物谱可预测对无麸质饮食的应答(p<0.001)。

核心结论

  • 无麸质饮食可能影响部分IBS患者的症状,尤其对排便习惯有特定作用。
  • 无麸质饮食似乎影响肠道微环境。
  • 对无麸质饮食的应答可能通过代谢物谱预测。

研究设计与样本

  • 随机对照试验,纳入20例IBS患者和18名健康对照。
  • 两个14天干预期,受试者在餐食上撒麸质(14克/天)或米粉。
  • 主要结局为干预对IBS症状(IBS-SSS)和排便习惯的影响;次要结局为无麸质饮食对粪便微生物群和代谢物谱的影响。

主要发现

  • 无麸质期IBS症状改善(p=0.02),含麸质期未改善,两种干预间无差异。
  • 无麸质干预期IBS患者报告稀便减少(p=0.01)。
  • IBS患者与健康对照基于无麸质饮食的影响呈现不同的代谢物谱(p<0.001)。
  • 真应答者(仅在无麸质期后IBS-SSS降低≥50)与非应答者可通过无麸质饮食对微生物群(p<0.01)和代谢物谱(p<0.001)的影响区分。
  • 干预前代谢物谱可预测对无麸质饮食的应答(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A gluten-free diet reduces symptoms in some patients with irritable bowel syndrome (IBS) through unclear mechanisms. AIMS: To assess the effects of gluten-free versus gluten-containing diet on symptoms and the gut microenvironment, and to identify predictors of response to the gluten-free diet in IBS METHODS: Twenty patients with IBS and 18 healthy controls (HC) followed a gluten-free diet during two 14-day intervention periods where they sprinkled either gluten (14 g/day) or rice flour powder over their meals. Primary outcomes included effects of the interventions on IBS symptoms (IBS-SSS) and bowel habits. Secondary outcomes included effects of gluten-free diet on faecal microbiota and metabolite profile. RESULTS: IBS symptoms improved during the gluten-free (p = 0.02), but not the gluten-containing period, with no difference between the interventions. IBS patients reported fewer loose stools during the gluten-free intervention (p = 0.01). Patients with IBS and HC presented distinct metabolite profiles based on the effects of the gluten-free diet (p < 0.001). True responders (reduced IBS-SSS by ≥50 solely after gluten-free period) and non-responders were discriminated based on the effects of the gluten-free diet on the microbiota (p < 0.01) and metabolite profiles (p < 0.001). The response to the gluten-free diet could be predicted by the metabolite profile before the intervention (p < 0.001). CONCLUSIONS: A gluten-free diet may influence symptoms in a subset of patients with IBS, with a particular effect on bowel habits. A gluten-free diet seems to impact the gut microenvironment. Responsiveness to the gluten-free diet may be predicted by the metabolite profile. CLINICALTRIALS: gov: NCT03869359.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Algera JP, Magnusson MK, Öhman L, et al. Randomised controlled trial: effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome. Aliment Pharmacol Ther. 2022. PMID: 36173041. doi:10.1111/apt.17239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。